Natixis’s Pediatrix Medical MD Stock Holding History

Natixis’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-12,964	Closed	-$211K	–	1080
2020 Q3	$211K	Hold	12,964	–	–	﹤0.01%	695
2020 Q2	$222K	Buy	+12,964	New	+$192K	﹤0.01%	684
2020 Q1	–	Sell	-178,721	Closed	-$4.86M	–	814
2019 Q4	$4.86M	Buy	+178,721	New	+$4.48M	0.03%	409
2019 Q3	–	Sell	-52,053	Closed	-$1.31M	–	879
2019 Q2	$1.31M	Sell	52,053 -272,425	-84%	-$7.32M	0.01%	493
2019 Q1	$8.87M	Buy	324,478 +144,942	+81%	+$4.86M	0.06%	292
2018 Q4	$5.92M	Buy	179,536 +210	+0.1%	+$8.44K	0.05%	296
2018 Q3	$8.37M	Buy	+179,326	New	+$8.23M	0.05%	304
2018 Q2	–	Sell	-97,048	Closed	-$5.4M	–	952
2018 Q1	$5.4M	Buy	+97,048	New	+$5.32M	0.03%	350
2017 Q4	–	Sell	-339,827	Closed	-$14.7M	–	1035
2017 Q3	$14.7M	Buy	339,827 +333,127	+4,972%	+$15.8M	0.14%	153
2017 Q2	$404K	Sell	6,700 -134	-2%	-$7.94K	﹤0.01%	566
2017 Q1	$474K	Buy	6,834 +2,402	+54%	+$167K	0.01%	525
2016 Q4	$295K	Buy	+4,432	New	+$288K	﹤0.01%	638

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

Natixis's MD Position: Q4 2020 in Review

Natixis sold out of Pediatrix Medical (MD) in Q4 2020, closing a stake of 12,964 shares — an estimated $211K sold.

Natixis first reported a position in MD in Q4 2016 and held it in 12 quarters. The position peaked at $14.7M in Q3 2017. 201 funds tracked by Wall St. Rank hold MD as of Q4 2020.

Natixis reported no remaining Pediatrix Medical position as of Q4 2020 after selling out during the quarter.
Natixis sold 12,964 Pediatrix Medical shares in Q4 2020, an estimated $211K.
Natixis first reported a position in Pediatrix Medical in Q4 2016 and held it in 12 quarters.
Natixis's Pediatrix Medical position peaked at $14.7M in Q3 2017.
201 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2020.

Based on Natixis's 13F filing for Q4 2020, filed 12 Feb 2021.